Ontology highlight
ABSTRACT: Background
High-intensity statin therapy is typically used in patients with acute myocardial infarction (AMI) for secondary prevention. However, there have been consistent concerns regarding its association with diabetes mellitus. We investigated the effect of high-intensity atorvastatin and rosuvastatin on new-onset diabetes mellitus (NODM) and cardiovascular outcomes over a 3-year follow-up period.Methods
Data from the Korea Acute Myocardial Infarction Registry were collected from November 2011 to October 2015, and 13,104 patients with AMI were enrolled from major cardiovascular centers. Among them, 2221 patients without diabetes who had been administered with high-intensity atorvastatin (40-80?mg) and rosuvastatin (20?mg) were investigated. The atorvastatin and rosuvastatin groups were evaluated for the incidence of NODM and major adverse cardiac events (MACE) including death, myocardial infarction, and revascularization cases in the following 3?years.Results
Baseline characteristics were comparable between the two groups. Event-free survival rate of NODM was not significantly different between the atorvastatin and rosuvastatin groups (92.5% vs. 90.8%, respectively; Log-rank P-value?=?0.550). The event-free survival rate of MACE was also not significantly different between atorvastatin and rosuvastatin groups (89.0% vs. 89.6%, respectively; Log rank P-value?=?0.662). Multivariate Cox analysis revealed that statin type was not a prognostic factor in the development of NODM and MACE.Conclusions
Administering high-intensity atorvastatin and rosuvastatin in patients with AMI produced comparable effects on NODM and clinical outcomes, suggesting their clinical equivalence in secondary prevention.
SUBMITTER: Choi JY
PROVIDER: S-EPMC7863364 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Choi Jah Yeon JY Choi Cheol Ung CU Choi Byoung Geol BG Park Yoonjee Y Kang Dong Oh DO Jang Won Young WY Kim Woohyeun W Na Jin Oh JO Kim Jin Won JW Kim Eung Ju EJ Rha Seung-Woon SW Park Chang Gyu CG Seo Hong Seog HS Jeong Myung Ho MH Chae Sung-Chull SC Seong In-Whan IW Yoon Chang-Hwan CH Cha Kwang Soo KS Oh Seok Kyu SK
BMC pharmacology & toxicology 20210204 1
<h4>Background</h4>High-intensity statin therapy is typically used in patients with acute myocardial infarction (AMI) for secondary prevention. However, there have been consistent concerns regarding its association with diabetes mellitus. We investigated the effect of high-intensity atorvastatin and rosuvastatin on new-onset diabetes mellitus (NODM) and cardiovascular outcomes over a 3-year follow-up period.<h4>Methods</h4>Data from the Korea Acute Myocardial Infarction Registry were collected f ...[more]